Leonteq Securities AG’s Editas Medicine EDIT Stock Holding History

Leonteq Securities AG’s Portfolio EDIT Stock Details EDIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.57K	Hold	1,409	–	–	﹤0.01%	1098
2026 Q1	$3.48K	Hold	1,409	–	–	﹤0.01%	1139
2025 Q4	$2.89K	Hold	1,409	–	–	﹤0.01%	1295
2025 Q3	$4.89K	Buy	1,409 +651	+86%	+$1.82K	﹤0.01%	1172
2025 Q2	$1.67K	Hold	758	–	–	﹤0.01%	1185
2025 Q1	$879	Hold	758	–	–	﹤0.01%	1172
2024 Q4	$963	Hold	758	–	–	﹤0.01%	1189
2024 Q3	$2.58K	Buy	758 +593	+359%	+$2.58K	﹤0.01%	1085
2024 Q2	$771	Buy	+165	New	+$931	﹤0.01%	1141
2021 Q4	–	Sell	-43	Closed	-$1.77K	–	1286
2021 Q3	$1.77K	Buy	+43	New	+$2.36K	﹤0.01%	1098

Other funds holding EDIT

TCM

TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Leonteq Securities AG's EDIT Position: Q2 2026 in Review

Leonteq Securities AG held its Editas Medicine (EDIT) position steady in Q2 2026 at 1,409 shares worth $4.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1098.

Leonteq Securities AG first reported a position in EDIT in Q3 2021 and has held it in 10 quarters since. The position peaked at $4.89K in Q3 2025. 214 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

Leonteq Securities AG held 1,409 shares of Editas Medicine worth $4.57K as of Q2 2026.
Leonteq Securities AG left its Editas Medicine share count unchanged in Q2 2026.
Editas Medicine made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1098 holding.
Leonteq Securities AG first reported a position in Editas Medicine in Q3 2021 and has held it in 10 quarters since.
Leonteq Securities AG's Editas Medicine position peaked at $4.89K in Q3 2025.
214 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.